Apollo Hospitals to integrate AI copilots and more AI briefs

Apollo Hospitals to adopt AI copilots from Microsoft

Apollo Hospitals will be adopting four AI copilots as part of its new collaboration with Microsoft. 

In a statement, the technology giant said it will help the hospital group develop and implement its AI roadmap, which will focus on expanding Apollo’s remote healthcare platform worldwide and building new technology solutions. 

This engagement is part of a string of strategic partnerships Microsoft has entered in the new year in India. It recently pledged a $3 billion investment in cloud and AI infrastructure in the country over the next two years. 

Besides the Indian government, Microsoft partnered with major industry players, including public broadband service provider RailTel, conglomerate Mahindra Group, finance company Bajaj Finance Ltd., and education technology platform upGrad, to “build a thriving AI ecosystem in India.” 

National Taiwan University Hospital’s telehealth system incorporates AI

National Taiwan University Hospital (NTUH) has integrated speech-to-text AI into its telehealth platform. 

The Intelligent Voice System on NTUH’s Fourth-Generation Telehealth Platform is based on a voice recognition technology provided by Chunghwa Telecom, Taiwan’s largest telecommunications service provider. Optimised for healthcare, Chunghwa’s technology was trained on voice data collected by the NTUH Telehealth Center. 

The AI-based voice recognition feature can convert a speaker’s mixed use of languages, such as Mandarin, English, Taiwanese, and accented Chinese, as well as medical terms, and bilingual drug names. 

This new feature also integrates NTUH’s emergency event prediction technology to predict possible emergency events within two weeks with nearly 9src% accuracy. 

NEC announces new pathology AI partnership

Japan-based NEC Corporation has partnered with a local AI company developing digital pathology solutions. 

In a statement, NEC said it will work with Biomy in enhancing the latter’s cloud-based automated digital pathology analytical platform DeepPathFinder to discover new pathological biomarkers.

They will later offer the enhanced digital pathology platform to pharmaceutical and biotechnology companies and academic institutions.